![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
01 TAKEDA PHARMA A/S (7)
02 Takeda Pharma (8)
03 Takeda Pharma AG (4)
01 ALOGLIPTIN BENZOATE (7)
02 ALOGLIPTIN BENZOATE; Metformin (2)
03 ALOGLIPTIN BENZOATE; Pioglitazone (2)
04 Alogliptin; Metformin hydrochloride (4)
05 Metformin; ALOGLIPTIN BENZOATE (2)
06 Pioglitazone; ALOGLIPTIN BENZOATE (2)
01 Italy (7)
02 Norway (8)
03 Switzerland (4)
01 Alogliptin 12.5Mg 28 Combined Oral Use (1)
02 Alogliptin 25Mg 28 Combined Oral Use (1)
03 Alogliptin 6,5Mg 28 Combined Oral Use (1)
04 Alogliptin+Metformin 12.5Mg+1.000Mg 56 Combined Oral Use (1)
05 Alogliptin+Metformin 12.5Mg+850Mg 28 Combined Oral Use (1)
06 Alogliptin+Pioglitazone 12.5Mg+30Mg 28 Combined Oral Use (1)
07 Alogliptin+Pioglitazone 25Mg+30Mg 28 Combined Oral Use (1)
08 Antic-calc Tablet, Film Coated (8)
09 Filmtable (4)